Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.

Kira Brämswig; Ferdinand Ploner; Alexandra Martel; Thomas Bauernhofer; Wolfgang Hilbe; Thomas Kühr; Clemens Leitgeb; Brigitte Mlineritsch; Andreas Petzer; Veronika Seebacher; Herbert Stöger; Michael Girschikofsky; Gerhard Hochreiner; Sigrun Ressler; Franz Romeder; Ewald Wöll; Thomas Brodowicz

doi:10.1097/CAD.0000000000000108

Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.

Kira Brämswig
, Ferdinand Ploner
, Alexandra Martel
, Thomas Bauernhofer
, Wolfgang Hilbe
, Thomas Kühr
, Clemens Leitgeb
, Brigitte Mlineritsch (Co-author)
, Andreas Petzer
, Veronika Seebacher
, Herbert Stöger
, Michael Girschikofsky
, Gerhard Hochreiner
, Sigrun Ressler (Co-author)
, Franz Romeder (Co-author)
, Ewald Wöll
, Thomas Brodowicz

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

7 Citations (Web of Science)

Original language	English
Pages (from-to)	848-853
Journal	ANTI-CANCER DRUGS
Volume	25
Issue number	7
DOIs	https://doi.org/10.1097/CAD.0000000000000108
Publication status	Published - 2014

Keywords

PHASE-II TRIAL
WEEKLY PACLITAXEL
SYSTEMIC THERAPY
LEIOMYOSARCOMA
ANGIOSARCOMA
TRABECTEDIN
CHEMOTHERAPY
STRATEGIES
CARCINOMA
RECURRENT

Access to Document

10.1097/CAD.0000000000000108

Cite this

Brämswig, K., Ploner, F., Martel, A., Bauernhofer, T., Hilbe, W., Kühr, T., Leitgeb, C., Mlineritsch, B., Petzer, A., Seebacher, V., Stöger, H., Girschikofsky, M., Hochreiner, G., Ressler, S., Romeder, F., Wöll, E., & Brodowicz, T. (2014). Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas. ANTI-CANCER DRUGS, 25(7), 848-853. https://doi.org/10.1097/CAD.0000000000000108

@article{da31cea07e6e49c98a47f354c508a7ae,

title = "Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.",

keywords = "PHASE-II TRIAL, WEEKLY PACLITAXEL, SYSTEMIC THERAPY, LEIOMYOSARCOMA, ANGIOSARCOMA, TRABECTEDIN, CHEMOTHERAPY, STRATEGIES, CARCINOMA, RECURRENT",

author = "Kira Br{\"a}mswig and Ferdinand Ploner and Alexandra Martel and Thomas Bauernhofer and Wolfgang Hilbe and Thomas K{\"u}hr and Clemens Leitgeb and Brigitte Mlineritsch and Andreas Petzer and Veronika Seebacher and Herbert St{\"o}ger and Michael Girschikofsky and Gerhard Hochreiner and Sigrun Ressler and Franz Romeder and Ewald W{\"o}ll and Thomas Brodowicz",

note = "(g)3(rd) Medical Department with Haematology, Medical Oncology, Haemostaseology, Rheumatology and Infectious Diseases, Paracelsus Medical University Salzburg, Salzburg (j)Department of Internal Medicine III, Center for Medical Oncology and Haematology, General Hospital Linz, Linz (k)Department of Internal Medicine, Saint Vincent Hospital Zams, Zams, Austria",

year = "2014",

doi = "10.1097/CAD.0000000000000108",

language = "English",

volume = "25",

pages = "848--853",

journal = "ANTI-CANCER DRUGS",

issn = "0959-4973",

publisher = "Lippincott Williams \& Wilkins ",

number = "7",

}

Brämswig, K, Ploner, F, Martel, A, Bauernhofer, T, Hilbe, W, Kühr, T, Leitgeb, C, Mlineritsch, B, Petzer, A, Seebacher, V, Stöger, H, Girschikofsky, M, Hochreiner, G, Ressler, S, Romeder, F, Wöll, E & Brodowicz, T 2014, 'Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.', ANTI-CANCER DRUGS, vol. 25, no. 7, pp. 848-853. https://doi.org/10.1097/CAD.0000000000000108

TY - JOUR

T1 - Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.

AU - Brämswig, Kira

AU - Ploner, Ferdinand

AU - Martel, Alexandra

AU - Bauernhofer, Thomas

AU - Hilbe, Wolfgang

AU - Kühr, Thomas

AU - Leitgeb, Clemens

AU - Mlineritsch, Brigitte

AU - Petzer, Andreas

AU - Seebacher, Veronika

AU - Stöger, Herbert

AU - Girschikofsky, Michael

AU - Hochreiner, Gerhard

AU - Ressler, Sigrun

AU - Romeder, Franz

AU - Wöll, Ewald

AU - Brodowicz, Thomas

N1 - (g)3(rd) Medical Department with Haematology, Medical Oncology, Haemostaseology, Rheumatology and Infectious Diseases, Paracelsus Medical University Salzburg, Salzburg (j)Department of Internal Medicine III, Center for Medical Oncology and Haematology, General Hospital Linz, Linz (k)Department of Internal Medicine, Saint Vincent Hospital Zams, Zams, Austria

PY - 2014

Y1 - 2014

KW - PHASE-II TRIAL

KW - WEEKLY PACLITAXEL

KW - SYSTEMIC THERAPY

KW - LEIOMYOSARCOMA

KW - ANGIOSARCOMA

KW - TRABECTEDIN

KW - CHEMOTHERAPY

KW - STRATEGIES

KW - CARCINOMA

KW - RECURRENT

U2 - 10.1097/CAD.0000000000000108

DO - 10.1097/CAD.0000000000000108

M3 - Original Article

C2 - 24667659

SN - 0959-4973

VL - 25

SP - 848

EP - 853

JO - ANTI-CANCER DRUGS

JF - ANTI-CANCER DRUGS

IS - 7

ER -